Anti-FANCD2 antibody [EPR2302]
- KO Validated
- RabMAb
- Recombinant
- What is this?
5
(4 Reviews)
|
(64 Publications)
Anti-FANCD2 antibody [EPR2302] (ab108928) is a rabbit monoclonal antibody detecting FANCD2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
View Alternative Names
FACD, FANCD2, Fanconi anemia group D2 protein, Protein FACD2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FANCD2 antibody [EPR2302] (AB108928)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human tonsil tissue sections labeling FANCD2 with purified ab108928 at 1/50 dilution (3.6 µg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-FANCD2 antibody [EPR2302] (AB108928)
ab108928 (unpurified) staining FANCD2 in wild-type HAP1 cells (top panel) and FANCD2 knockout HAP1 cells (bottom panel). The cells were fixed with 4% formaldehyde (10 minutes), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1 hour. The cells were then incubated with ab108928 at 1/250 dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1 hour with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
- ICC/IF
AbReview42329****
Immunocytochemistry/ Immunofluorescence - Anti-FANCD2 antibody [EPR2302] (AB108928)
ab108928 (unpurified) staining FANCD2 in human U2OS osteosarcoma cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.5% Triton X-100 and blocked with 10% goat serum for 1 hour at 20°C. Samples were incubated with primary antibody (1/300) for 18 hours at 4°C. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG monoclonal (1/1000) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-FANCD2 antibody [EPR2302] (AB108928)
Intracellular Flow Cytometry analysis of Jurkat (human acute T cell leukemia) cells labeling FANCD2 (red) with ab108928 (purified) at a 1/200 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with primary and secondary antibodies.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-FANCD2 antibody [EPR2302] (AB108928)
HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for FANCD2 (green) using ab108928 (unpurified) (1/250 dilution) in ICC/IF.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FANCD2 antibody [EPR2302] (AB108928)
Immunohistochemical staining of paraffin-embedded human tonsil tissue using ab108928 (unpurified) at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-FANCD2 antibody [EPR2302] (AB108928)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling FANCD2 with purified ab108928 at 1/500 dilution (0.4 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 (2.5 μg/ml) dilution. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IP
Unknown
Immunoprecipitation - Anti-FANCD2 antibody [EPR2302] (AB108928)
ab108928 (purified) at 1/20 dilution (1ug) immunoprecipitating FANCD2 in HeLa whole cell lysates.
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates 10ug
Lane 2 (+) : ab108928 & HeLa whole cell lysates
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108928 in HeLa whole cell lysates
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-FANCD2 antibody [EPR2302] (ab108928)
Predicted band size: 166 kDa
false
- WB
Lab
Western blot - Anti-FANCD2 antibody [EPR2302] (AB108928)
Western blot : Anti-FANCD2 antibody [EPR2302] (ab108928) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab108928 was shown to bind specifically to FANCD2. A band was observed at 160 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in FANCD2 knockout cell line. To generate this image, wild-type and FANCD2 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-FANCD2 antibody [EPR2302] (ab108928) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
Western blot - Human FANCD2 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-fancd2-knockout-hct116-cell-line-ab286588'>ab286588</a>)
Lane 2:
FANCD2 knockout HCT 116 cell lysate at 20 µg
Lane 3:
Wild-type HeLa ab255448 cell lysate at 20 µg
Lane 4:
FANCD2 knockout HeLa <a href='/en-us/products/cell-lines/human-fancd2-knockout-hela-cell-line-ab261743'>ab261743</a> cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 160 kDa
false
- WB
Lab
Western blot - Anti-FANCD2 antibody [EPR2302] (AB108928)
Lanes 1- 2 : Merged signal (red and green). Green - ab108928 observed at 166 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab108928 was shown to react with FANCD2 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261743 (knockout cell lysate ab257173) was used. Wild-type HeLa and FANCD2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab108928 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FANCD2 antibody [EPR2302] (ab108928) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FANCD2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FANCD2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fancd2-knockout-hela-cell-line-ab261743'>ab261743</a>)
Predicted band size: 166 kDa
Observed band size: 166 kDa
false
- WB
Lab
Western blot - Anti-FANCD2 antibody [EPR2302] (AB108928)
All lanes:
Western blot - Anti-FANCD2 antibody [EPR2302] (ab108928) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 3:
C6 (Rat glial tumor glial cell) whole cell lysates at 20 µg
Lane 4:
RAW264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates at 20 µg
Lane 5:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 166 kDa
Observed band size: 165 kDa
false
- WB
Lab
Western blot - Anti-FANCD2 antibody [EPR2302] (AB108928)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : FANCD2 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : HEK293 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab108928 (unpurified) observed at 165 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab108928 was shown to specifically react with FANCD2 when FANCD2 knockout samples were used. Wild-type and FANCD2 knockout samples were subjected to SDS-PAGE. ab108928 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FANCD2 antibody [EPR2302] (ab108928)
Predicted band size: 166 kDa
false
Related conjugates and formulations (10)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FANCD2 antibody [EPR2302]
-
578 PE
PE Anti-FANCD2 antibody [EPR2302]
-
660 APC
APC Anti-FANCD2 antibody [EPR2302]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-FANCD2 antibody [EPR2302]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-FANCD2 antibody [EPR2302]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-FANCD2 antibody [EPR2302]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-FANCD2 antibody [EPR2302]
-
Anti-FANCD2 antibody [EPR2302] - BSA and Azide free
-
HRP Anti-FANCD2 antibody [EPR2302]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-FANCD2 antibody [EPR2302]
Reactivity data
Product details
What is this antibody validated in?
Anti-FANCD2 antibody [EPR2302] (ab108928) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of FANCD2?
Anti-FANCD2 [EPR2302] (ab108928) specifically detects a band for FANCD2 (UniProt: Q9BXW9) at a molecular weight of 166kDa.
Trusted by the scientific community
Anti-FANCD2 [EPR2302] (ab108928) was first used in a scientific publication in 2011 and has been cited over 40 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-FANCD2 antibody [EPR2302] (ab108928) has been confirmed by Western blot testing in FANCD2 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR2302] also available for your convenience: ab108928, Alexa Fluor® 488 - ab200759, Alexa Fluor® 647 - ab200763, Carrier free - ab221932, PE - ab307174, APC - ab307175, HRP - ab307176, Alkaline Phosphatase - ab308832, Alexa Fluor® 594 - ab310563, Alexa Fluor® 555 - ab312092, Alexa Fluor® 568 - ab312572, Alexa Fluor® 750 - ab320916
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FANCD2 collaborates with multiple proteins as part of the Fanconi anemia (FA) complex to ensure genomic stability. The FA complex operates by facilitating the repair of DNA interstrand crosslinks that impede replication. FANCD2 becomes activated through monoubiquitination which serves as a signal for recruitment to DNA damage sites. It essentially functions as a coordinator that brings together important components for repair.
Pathways
FANCD2 integrates into the Fanconi anemia pathway and the homologous recombination repair pathway. These pathways are critical for maintaining DNA integrity and preventing chromosomal instability. Within these pathways interactions with proteins such as BRCA1 and BRCA2 reinforce the repair processes. FANCD2's connection to these proteins exemplifies its role in complex mechanisms that preserve genomic fidelity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (64)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8476 PubMed41006228
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:7566 PubMed40813572
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 30:422 PubMed40688582
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2159 PubMed40038300
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 13:e70103 PubMed39149814
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:6755 PubMed39117659
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 14:1389472 PubMed38711848
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109456 PubMed38591005
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:1446 PubMed38365788
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 52:2389-2415 PubMed38224453
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com